Pharmaceutical characterization of novel tenofovir liposomal formulations for enhanced oral drug delivery: in vitro pharmaceutics and Caco-2 permeability investigations

References

• SaxPEWohlDYinMTGS-US-292-0104/0111 Study TeamTenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trialsLancet201538599872606261525890673
   PubMed Web of Science ®Google Scholar
• RayASFordyceMWHitchcockMJTenofovir alafenamide: a novel prodrug of tenofovir for the treatment of human immunodeficiency virusAntiviral Res2016125637026640223
   PubMed Web of Science ®Google Scholar
• VIREAD® (tenofovir disoproxil fumarate). Viread-Labeling [package insert]USAGilead Sciences, Inc.21-356-GS-0352015150 Available from: http://www.gilead.com/~/media/files/pdfs/medicines/liver-disease/viread/viread_pi.pdfAccessed August 16, 2016
   Google Scholar
• SentenacSFernandezCThuillierALechatPAymardGSensitive determination of tenofovir in human plasma samples using reversed-phase liquid chromatographyJ Chromatogr B Analyt Technol Biomed Life Sci20037932317324
   PubMed Web of Science ®Google Scholar
• O’NeilMJHeckelmanPEDobbelaarPHRomanKJKennyCMKaraffaLSThe Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals15th edCambridgeRoyal Society of Chemistry2013
   Google Scholar
• FungHBStoneEAPiacentiFJTenofovir disoproxil fumarate: a nucleotide reverse transcriptase inhibitor for the treatment of HIV infectionClin Ther200224101515154812462284
   PubMed Web of Science ®Google Scholar
• SharmaASharmaUSLiposomes in drug delivery: progress and limitationsInt J Pharm19971542123140
   Web of Science ®Google Scholar
• Barditch-CrovoPDeeksSGCollierAPhase I/II trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adultsAntimicrob Agents Chemother200145102733273911557462
   PubMed Web of Science ®Google Scholar
• SchooleyRRuanePMyersRTenofovir disoproxil fumarate (TDF) for the treatment of antiretroviral experienced patients: a 48 week analysis of a randomized, double blind, placebo-controlled studyAIDS200014S6S7
   Web of Science ®Google Scholar
• GiacaloneGHillaireauHFattalEImproving bioavailability and bio-distribution of anti-HIV chemotherapyEur J Pharm Sci201575405325937367
   PubMed Web of Science ®Google Scholar
• PozniakATenofovir: what have over 1 million years of patient experience taught us?Int J Clin Pract20086281285129318705824
   PubMed Web of Science ®Google Scholar
• ZidanASHabibMJMaximized mucoadhesion and skin permeation of anti-AIDS-loaded niosomal gelsJ Pharm Sci2014103395296424464823
   PubMed Web of Science ®Google Scholar
• VargaAGraczerEChaloinLSelectivity of kinases on the activation of tenofovir, an anti-HIV agentEur J Pharm Sci2013481–230731523201309
   PubMed Web of Science ®Google Scholar
• HirtDUrienSEkoueviDKPopulation pharmacokinetics of tenofovir in HIV-1-infected pregnant women and their neonates (ANRS 12109)Clin Pharmacol Ther200985218218918987623
   PubMed Web of Science ®Google Scholar
• SosnikAChiappettaDACarcabosoAMDrug delivery systems in HIV pharmacotherapy: what has been done and the challenges standing aheadJ Control Release2009138121519445981
   PubMed Web of Science ®Google Scholar
• EloyJOClaro de SouzaMPetrilliRBarcellosJPALeeRJMarchettiJMLiposomes as carriers of hydrophilic small molecule drugs: strategies to enhance encapsulation and deliveryColloids Surf B Biointerfaces2014123034536325280609
   PubMed Web of Science ®Google Scholar
• DesormeauxABergeronMGLiposomes as drug delivery system: a strategic approach for the treatment of HIV infectionJ Drug Target1998611159769017
   PubMed Web of Science ®Google Scholar
• JinSXBiDZWangJWangYZHuHGDengYHPharmacokinetics and tissue distribution of zidovudine in rats following intravenous administration of zidovudine myristate loaded liposomesPharmazie2005601184084316320946
   PubMed Web of Science ®Google Scholar
• FDA-Guidance-for-IndustryLiposome Drug Products; Chemistry, Manufacturing, and Controls; Human Pharmacokinetics and Bio-availability; and Labeling DocumentationGuidance for Industry2015 Revision I(Draft Guidance)114 Available from: http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm070570.pdfAccessed June 13, 2016
   Google Scholar
• KandagalPBManjunathaDHSeetharamappaJKalanurSSRP-HPLC method for the determination of tenofovir in pharmaceutical formulations and spiked human plasmaAnal Lett2008414561570
   Web of Science ®Google Scholar
• Rodriguez-NovoaSMorelloJBarreiroPSwitch from ritonavir-boosted to unboosted atazanavir guided by therapeutic drug monitoringAIDS Res Hum Retroviruses200824682182518507524
   PubMed Web of Science ®Google Scholar
• BezyVMorinPCouerbePLeleuGAgrofoglioLSimultaneous analysis of several antiretroviral nucleosides in rat-plasma by high-performance liquid chromatography with UV using acetic acid/hydroxylamine buffer – test of this new volatile medium-pH for HPLC-ESI-MS/MSJ Chromatogr B Analyt Technol Biomed Life Sci20058212132143
   PubMed Web of Science ®Google Scholar
• Le SauxTChhunSReyEQuantification of seven nucleoside/nucleotide reverse transcriptase inhibitors in human plasma by high-performance liquid chromatography with tandem mass-spectrometryJ Chromatogr B Analyt Technol Biomed Life Sci20088651–28190
   Web of Science ®Google Scholar
• VourvahisMTappouniHLPattersonKBThe pharmacokinetics and viral activity of tenofovir in the male genital tractJ Acquir Immune Defic Syndr200847332933318197124
   PubMed Web of Science ®Google Scholar
• AnthonypillaiCGibbsJEThomasSAThe distribution of the anti-HIV drug, tenofovir (PMPA), into the brain, CSF and choroid plexusesCerebrospinal Fluid Res200631116390539
   PubMedGoogle Scholar
• RezkNLCrutchleyRDKashubaADMSimultaneous quantification of emtricitabine and tenofovir in human plasma using high-performance liquid chromatography after solid phase extractionJ Chromatogr B Analyt Technol Biomed Life Sci20058221–2201208
   Web of Science ®Google Scholar
• ZidanASSpinksCFortunakJHabibMKhanMANear-infrared investigations of novel anti-HIV tenofovir liposomesAAPS J201012220221420195931
   PubMed Web of Science ®Google Scholar
• VolpeDAFaustinoPJCiavarellaABClassification of drug permeability with a Caco-2 cell monolayer assayClin Res Regul Affairs20072413947
   Google Scholar
• PalumboPPicchiniUBeckBvan GelderJDelbarNDeGaetanoAA general approach to the apparent permeability indexJ Pharmacokinet Pharmacodyn200835223524818351296
   PubMed Web of Science ®Google Scholar
• SuhelPBahelUSRajeshPProbhakarDEnglaGNagarPNSpectrophotometric method development and validation for simultaneous estimation of tenofovir disoproxil fumarate and emtricitabine in bulk drug and table dosage formInt J Pharm Clin Res2009112830
   Google Scholar
• International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use; 2005ICH Harmonised Tripartite Guideline. Validation of Analytical Procedures: Text and Methodology Q2 (R1) Available from: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q2_R1/Step4/Q2_R1__Guideline.pdfAccessed January 11, 2017
   Google Scholar
• RamaswamyAArulGnanaDhasASDevelopment and validation of analytical method for quantitation of emtricitabine, tenofovir, efavirenz based on HPLCArabian J Chem Epub8272014 Available at: http://www.sciencedirect.com/science/article/pii/S1878535214001695Accessed August 16, 2016
   Google Scholar
• AshourHKBelalTSNew simple spectrophotometric method for determination of the antiviral mixture of emtricitabine and tenofovir disoproxil fumarateArabian J Chem Epub6282013 Available at: http://www.sciencedirect.com/science/article/pii/S1878535213001883Accessed August 16, 2016
   Google Scholar
• CDER-Guidline. Reviewer guidance: validation of chromatographic methodsReviewer Guidance1994133 Available from: http://www.fda.gov/downloads/Drugs/Guidances/UCM134409.pdfAccessed August 27, 2015
   Google Scholar
• KulkarniSBBetageriGVSinghMFactors affecting microencapsulation of drugs in liposomesJ Microencapsul19951232292467650588
   PubMed Web of Science ®Google Scholar
• DeleersMGuilminTVandenbrandenMRuysschaertJMThermotropic properties of dipalmitoyl phosphatidyl choline stearylamine liposomesPharmacol Res Commun1982144333339
   Google Scholar
• DeleersMMalaisseWJIonophore-mediated calcium exchange diffusion in liposomesBiochem Biophys Res Commun19809526506576774713
   PubMed Web of Science ®Google Scholar
• KrishnaGChenKLinCNomeirAAPermeability of lipophilic compounds in drug discovery using in-vitro human absorption model, Caco-2Int J Pharm20012223778911404034
   PubMed Web of Science ®Google Scholar